Store
The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030
Publication Date: August 19, 2026
Tags: Clinical, Clinical Diagnostics, Immunoassay, Life Science, Life Sciences, Mass Spectrometry, Pharmaceuticals, Proteomics Tools, Sequencing, Sequencing Technologies
Pages: 105
SKU: 26-042KA
Kalorama Information’s The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 examines the market for proteomics technologies as applied to clinical and pharmaceutical settings, with particular attention to next-generation platforms — the instruments, consumables, and reagent kits that enable systematic, multiplexed protein measurement for clinical research, trial biomarker work, and, increasingly, patient diagnostics.
The report addresses a central tension in this field: most revenue currently associated with “clinical” proteomics comes from research and pharmaceutical development rather than diagnostic testing. Systematic and multiplex protein analysis platforms are widely used in biomarker discovery, trial stratification, and population-scale studies, while a smaller number of applications — concentrated in neurology, certain cancers, and oncology triage — have reached actual clinical use. The report tracks the technologies, companies, and commercial developments defining how that landscape is evolving.
Coverage includes the major measurement approaches shaping the field — mass spectrometry, high-plex affinity and binder-based assays, ultrasensitive digital immunoassays, spatial and single-cell proteomics, and emerging single-molecule protein sequencing — along with the enrichment, separation, and sample-preparation technologies that support them. The report discusses key structural trends affecting the market, including the ongoing consolidation of proteomics companies into larger instrument and diagnostics platforms, the migration of affinity-based assays onto sequencing and PCR infrastructure, the role of the LDT/CLIA regulatory pathway in clinical commercialization, and the shifting balance between instrument sales and services-based revenue.
The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 provides estimated market size data segmented by technology and region for 2025, profiles of companies active across the proteomics value chain, and a review of recent product introductions, regulatory approvals, and deal activity shaping the competitive environment.
Scope and methodology
The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 focuses on instrument, consumable, and reagent/kit revenue associated with systematic or multiplexed protein analysis technologies used in clinical research, clinical trial biomarker measurement, and clinical diagnostics. Contract research and clinical laboratory testing services are discussed but are not included in the core revenue estimates, in part to avoid double-counting revenue already reflected in product sales. Research for this report draws on primary interviews, company financial disclosures, product literature, conference proceedings, and journal and trade publication review.
Research Designed for C-Suite Executives, Key Companies, and More
The Clinical Proteomics Market: Technologies, Applications, and Forecasts to 2030 is intended for executives, strategy and business development teams, investors, laboratory and pharmaceutical biomarker leaders, and marketing professionals working in or evaluating the clinical proteomics space.
Chapter 1: Executive Summary
About Kalorama Information
Introduction
Overview
Trends Affecting the Market
Size of Market
- Table 1-1: Proteomics Clinical Applications Market Revenues, 2025-2030 (US$ millions)
- Figure 1-1: Proteomics Clinical Applications Market Revenues, 2025-2030 (US$ millions)
- Figure 1-2: Proteomics Clinical Applications Annual Market Growth, 2025-2030 (%)
Scope and Methodology
Chapter 2: Technologies and Products
Introduction
Technologies Used in Clinical Applications of Proteomics
Mass Spectrometry
High-Plex Capable Affinity Techniques
Spatial Proteomics
Mass Cytometry
Automated and Capillary Western
Single-Molecule Protein Sequencing
Products Offered in Clinical Proteomics Areas
Analysis / Detection Platforms
- Table 2-1: Selected Analysis and Detection Technologies in Clinical Proteomics
Mass Spectrometry Based Technologies
- Table 2-2: Selected Mass Spectrometry Technologies in Clinical Proteomics
Affinity and Binder Based Techniques
- Table 2-3: Selected Affinity and Binder Based Techniques in Clinical Proteomics
Enrichment, Separation, Sample Preparation
- Table 2-4: Selected Enrichment, Separation, Sample Preparation Products and Technologies
Spatial Proteomics and Imaging Techniques
- Table 2-5: Selected Spatial Proteomics and Imaging Techniques in Clinical Proteomics
Software and Informatics
- Table 2-6: Selected Software and Informatics in Clinical Proteomics
Clinical Diagnostic and Biomarker Tests
- Table 2-7: Selected Diagnostic Tests in or Related to Clinical Proteomics
Services and Contract Research
- Table 2-8: Selected Services in Clinical Proteomics
Chapter 3: Trends
Introduction
Consolidation as Larger Companies Focus Strategy
Detection Methods Competing, Some Converging
Sequencing Infrastructure Applied as Proteomics Readout
Dynamic Range and Sensitivity Are Battleground
Cost and Throughput Unlocking Population-Scale Proteomics
Neurology Emerges as Beachhead Clinical Application
Oncology Broadening From Detection
Commercialization Often Using LDT/CLIA Model
Spatial and Single-Cell Proteomics on Frontier
Capital Markets Soft, Services and Pharma Steadier Ground
Evolving Technologies and Adjacent Products
Recent Product Introductions and Regulatory Approvals
- Table 3-1: Recent Product / Service Announcements, 2021-2026
- Table 3-2: Regulatory Approvals and Related Announcements, 2021-2026
Deals, Collaborations, Acquisitions
- Table 3-3: Deals, Collaborations, Acquisitions in Clinical Applications of Proteomics
Chapter 4: Market Estimate and Forecast
Introduction
Market Size and Forecast by Segment
- Table 4-1: Proteomics Clinical Applications Market Revenues, 2025-2030 (US$ millions)
- Figure 4-1: Proteomics Clinical Applications Market Revenue Build, 2025-2030 (US$ millions)
Market Size by Region
- Table 4-2: Proteomics Clinical Applications Market, by Region, 2025 (US$ millions)
- Figure 4-2: Proteomics Clinical Applications Market, by Region, 2025 (US$ millions)
- Figure 4-3: Proteomics Clinical Applications Market Share, by Region, 2025 (%)
Market Size by Technology
- Table 4-3: Proteomics Clinical Applications Market, by Technology, 2025 (US$ millions) [Affinity-based, MS-based, Ultrasensitive digital immunoassay, Other]
- Figure 4-4: Proteomics Clinical Applications Market, by Technology, 2025 (US$ millions) [Affinity-based, MS-based, Ultrasensitive digital immunoassay, Other]
- Figure 4-5: Proteomics Clinical Applications Market Share, by Technology, 2025 (%) [Affinity-based, MS-based, Ultrasensitive digital immunoassay, Other]
Chapter 5: Company Profiles
Introduction
Alamar Biosciences
Bio-Techne
Bruker
Cellenion
Evosep
Illumina
Nanomics
NanoMosaic
Nautilus Biotechnology
Nomic Bio
Quanterix
Quantum-Si
SCIEX
Seer
Standard BioTools
Thermo Fisher Scientific
Related products
In Vitro Diagnostic (IVD) Trends and Market Update: December 2024
December 6, 2024
The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product…
Price range: $5,000.00 through $7,875.00
Worldwide Sequencer Market, 2023-2028
August 7, 2024
Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.
The report offers historical data for 2023…
Price range: $5,000.00 through $7,875.00
SDi 2022 Instrumentation Installed Base DataFile
August 3, 2022
For customers seeking to know not just the market for laboratory instruments, but how many instruments there are, SDi releases here a supplemental spreadsheet deliverable for the 83 analytical technologies covered in the Global Assessment Report 2022.
The SDi Instrumentation Installed Base DataFile covers 270 instrument types in total, providing 2021 estimates of average price,…
$7,500.00
